SOMERSET THERAPEUTICS LLC: Cisatracurium Besylate Injection USP, 20 mg/10 mL*,(2 mg/mL), 10 x 10 mL Multiple-dose Vials per carton, Rx Only, Manufactured for: Somerset
Read the official notice at FDA (drug) →
Get alerts for Somerset Therapeutics
The text below is copied from the official FDA (drug) record. If anything differs, the official notice is correct.
- Company / brand
- SOMERSET THERAPEUTICS LLC
- Product
- Cisatracurium Besylate Injection USP, 20 mg/10 mL*,(2 mg/mL), 10 x 10 mL Multiple-dose Vials per carton, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Hollywood, FL 33024, Made in India, 10mL Multiple-dose vial, NDC 70069-161-01; 10x10mL Multiple-dose vials per Carton, NDC 70069-161-01.
- Reason / hazard
- Subpotent product:out of specification assay results observed during long term stability testing.
- Classification
- Class III
- Status
- Ongoing
- Distribution / sold at
- Nationwide in the USA
- Recall initiated
- 2025-11-26
- Code info
- Lot#: A250043, EXP Date 06/30/2026
- Product quantity
- 71,310 10mL vials
- Voluntary mandated
- Voluntary: Firm initiated
- City
- Somerset
- State
- NJ
- Country
- United States
- Event id
- 98063
Free daily digest + "My products" watchlist